68 related articles for article (PubMed ID: 38701314)
1. AKR1B10 expression characteristics in hepatocellular carcinoma and its correlation with clinicopathological features and immune microenvironment.
Ma LN; Ma Y; Luo X; Ma ZM; Ma LN; Ding XC
Sci Rep; 2024 May; 14(1):12149. PubMed ID: 38802416
[TBL] [Abstract][Full Text] [Related]
2. Constructing immune and prognostic features associated with ADCP in hepatocellular carcinoma and pan-cancer based on scRNA-seq and bulk RNA-seq.
Zhang Z; Li Y; Quan Z; Li Y; Zhu L; Sun S; Chen X
Front Immunol; 2024; 15():1397541. PubMed ID: 38774870
[TBL] [Abstract][Full Text] [Related]
3. Dichotomous roles of ADAR1 in liver hepatocellular carcinoma and kidney renal cell carcinoma: Unraveling the complex tumor microenvironment and prognostic significance.
Mao JX; Li JJ; Lu XY; Zhong HX; Zhao YY; Zhu LY; Fu H; Ding GS; Teng F; Chen M; Guo WY
Int Immunopharmacol; 2024 May; 136():112340. PubMed ID: 38820962
[TBL] [Abstract][Full Text] [Related]
4. Targeting PRKDC activates the efficacy of antitumor immunity while sensitizing chemotherapy and targeted therapy in liver hepatocellular carcinoma.
Pan Y; Zhu Q; Hong T; Cheng J; Tang X
Aging (Albany NY); 2024 May; 16():. PubMed ID: 38787389
[TBL] [Abstract][Full Text] [Related]
5. Exploring the role of CDCA4 in liver hepatocellular carcinoma using bioinformatics analysis and experiments.
Liang C; Long K; Zheng W; Zhong R; Li Z; Zhu S; Gu S; Zhu C; Yang Y
Medicine (Baltimore); 2024 May; 103(18):e38028. PubMed ID: 38701314
[TBL] [Abstract][Full Text] [Related]
6. A Pan-Cancer Analysis of the Oncogenic Role of Cell Division Cycle-Associated Protein 4 (CDCA4) in Human Tumors.
Fang H; Sheng S; Chen B; Wang J; Mao D; Han Y; Liu Y; Wang X; Gui S; Zhang T; Zhang L; Li C; Hu X; Deng W; Liu X; Xu H; Xu W; Wang X; Liu R; Kong W
Front Immunol; 2022; 13():826337. PubMed ID: 35251007
[TBL] [Abstract][Full Text] [Related]
7. LINC00638/hsa-miR-29b-3p axis-mediated high expression of CDCA4 correlates with tumor immune infiltration and hepatocellular carcinoma progression.
Wang B; Chen L; Li Q; Zhou J; Jin W
Transl Cancer Res; 2023 May; 12(5):1290-1306. PubMed ID: 37304553
[TBL] [Abstract][Full Text] [Related]
8. Construction of liver hepatocellular carcinoma-specific lncRNA-miRNA-mRNA network based on bioinformatics analysis.
Wang R; Hu X; Liu X; Bai L; Gu J; Li Q
PLoS One; 2021; 16(4):e0249881. PubMed ID: 33861762
[TBL] [Abstract][Full Text] [Related]
9. Integrative analysis unveils ECM signatures and pathways driving hepatocellular carcinoma progression: A multi-omics approach and prognostic model development.
Liu Z; Zhao P
J Cell Mol Med; 2024 Apr; 28(8):e18230. PubMed ID: 38568083
[TBL] [Abstract][Full Text] [Related]
10. PDCL3 is a prognostic biomarker associated with immune infiltration in hepatocellular carcinoma.
Jin W; Wang G; Dong M; Wang X
Eur J Med Res; 2024 Mar; 29(1):177. PubMed ID: 38494503
[TBL] [Abstract][Full Text] [Related]
11. Systematic analysis of the prognostic value and immunological function of LTBR in human cancer.
Wu Y; Zhao S; Guo W; Liu Y; Requena Mullor MDM; Rodrìguez RA; Wei R
Aging (Albany NY); 2024 Jan; 16(1):129-152. PubMed ID: 38175686
[TBL] [Abstract][Full Text] [Related]
12. Analysis and modeling of cancer drug responses using cell cycle phase-specific rate effects.
Gross SM; Mohammadi F; Sanchez-Aguila C; Zhan PJ; Liby TA; Dane MA; Meyer AS; Heiser LM
Nat Commun; 2023 Jun; 14(1):3450. PubMed ID: 37301933
[TBL] [Abstract][Full Text] [Related]
13. Natural compounds ursolic acid and digoxin exhibit inhibitory activities to cancer cells in RORγ-dependent and -independent manner.
Zou H; Yang Y; Chen HW
Front Pharmacol; 2023; 14():1146741. PubMed ID: 37180705
[TBL] [Abstract][Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
